wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35671077-4E5D7C0E-D242-4B39-868D-EDE942650A51
Q35671077-4E5D7C0E-D242-4B39-868D-EDE942650A51
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35671077-4E5D7C0E-D242-4B39-868D-EDE942650A51
Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials
P2860
Q35671077-4E5D7C0E-D242-4B39-868D-EDE942650A51
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35671077-4E5D7C0E-D242-4B39-868D-EDE942650A51
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
983b55003954d5ac199977af77f5d19cf71776c4
P2860
Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial.